Structure of the voltage-gated potassium channel K_V1.3: Insights into the inactivated conformation and binding to therapeutic leads

References

• DeCoursey TE, Chandy KG, Gupta S, et al. Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature. 1984;307(5950):465–20. doi: 10.1038/307465a0
   PubMed Web of Science ®Google Scholar
• Matteson DR, Deutsch C. K channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion. Nature. 1984;307(5950):468–471. doi: 10.1038/307468a0
   PubMed Web of Science ®Google Scholar
• Chandy KG, DeCoursey TE, Cahalan MD, et al. Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med. 1984;160(2):369–385. doi: 10.1084/jem.160.2.369
   PubMed Web of Science ®Google Scholar
• Cahalan MD, Chandy KG, DeCoursey TE, et al. A voltage-gated potassium channel in human T lymphocytes. J Physiol. 1985;358(1):197–237. doi: 10.1113/jphysiol.1985.sp015548
   PubMed Web of Science ®Google Scholar
• Price M, Lee SC, Deutsch C. Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes. Proc Natl Acad Sci U S A. 1989;86(24):10171–10175. doi: 10.1073/pnas.86.24.10171
   PubMed Web of Science ®Google Scholar
• Douglass J, Osborne PB, Cai YC, et al. Characterization and functional expression of a rat genomic DNA clone encoding a lymphocyte potassium channel. J Immunol. 1990;144(12):4841–4850. doi: 10.4049/jimmunol.144.12.4841
   PubMed Web of Science ®Google Scholar
• Grissmer S, Dethlefs B, Wasmuth JJ, et al. Expression and chromosomal localization of a lymphocyte K+ channel gene. Proc Natl Acad Sci U S A. 1990;87(23):9411–9415. doi: 10.1073/pnas.87.23.9411
   PubMed Web of Science ®Google Scholar
• Cahalan MD, Chandy KG. The functional network of ion channels in T lymphocytes. Immunol Rev. 2009;231(1):59–87. doi: 10.1111/j.1600-065X.2009.00816.x
   PubMedGoogle Scholar
• Feske S, Wulff H, Skolnik EY. Ion channels in innate and adaptive immunity. Annu Rev Immunol. 2015;33(1):291–353. doi: 10.1146/annurev-immunol-032414-112212
   PubMed Web of Science ®Google Scholar
• Erdogmus S, Concepcion AR, Yamashita M, et al. Cavbeta1 regulates T cell expansion and apoptosis independently of voltage-gated Ca2+ channel function. Nat Commun. 2022;13(1):2033. doi: 10.1038/s41467-022-29725-3
   PubMed Web of Science ®Google Scholar
• Zhang SL, Yu Y, Roos J, et al. STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature. 2005;437(7060):902–905. doi: 10.1038/nature04147
   PubMed Web of Science ®Google Scholar
• Feske S, Gwack Y, Prakriya M, et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature. 2006;441(7090):179–185. doi: 10.1038/nature04702
   PubMed Web of Science ®Google Scholar
• Vig M, Peinelt C, Beck A, et al. CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science. 2006;312(5777):1220–1223. doi: 10.1126/science.1127883
   PubMed Web of Science ®Google Scholar
• Zhang SL, Yeromin AV, Zhang XH, et al. Genome-wide RNAi screen of Ca2+ influx identifies genes that regulate Ca2+ release-activated Ca2+ channel activity. Proc Natl Acad Sci U S A. 2006;103(24):9357–9362. doi: 10.1073/pnas.0603161103
   PubMed Web of Science ®Google Scholar
• Oh-Hora M, Yamashita M, Hogan PG, et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat Immunol. 2008;9(4):432–443. doi: 10.1038/ni1574
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Weidinger C, Vaeth M, et al. CD4+ and CD8+ T cell-dependent antiviral immunity requires STIM1 and STIM2. J Clin Invest. 2014;124(10):4549–4563. doi: 10.1172/JCI76602
   PubMed Web of Science ®Google Scholar
• Vaeth M, Yang J, Yamashita M, et al. ORAI2 modulates store-operated calcium entry and T cell-mediated immunity. Nat Commun. 2017;8(1):14714. doi: 10.1038/ncomms14714
   PubMedGoogle Scholar
• Chandy KG, Norton RS. Peptide blockers of KV1.3 channels in T cells as therapeutics for autoimmune disease. Curr Opin Chem Biol. 2017;38:97–107. doi: 10.1016/j.cbpa.2017.02.015
   PubMed Web of Science ®Google Scholar
• Wulff H, Christophersen P, Colussi P, et al. Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019;18(5):339–357. doi: 10.1038/s41573-019-0013-8
   PubMed Web of Science ®Google Scholar
• Nguyen HM, Grossinger EM, Horiuchi M, et al. Differential KV1.3, KCa3.1, and Kir2.1 expression in “classically” and “alternatively” activated microglia. Glia. 2017;65(1):106–121. doi: 10.1002/glia.23078
   PubMed Web of Science ®Google Scholar
• Nguyen HM, Blomster LV, Christophersen P, et al. Potassium channel expression and function in microglia: plasticity and possible species variations. Channels (Austin). 2017;11(4):305–315. doi: 10.1080/19336950.2017.1300738
   PubMed Web of Science ®Google Scholar
• Immler R, Nadolni W, Bertsch A, et al. The voltage-gated potassium channel KV1.3 regulates neutrophil recruitment during inflammation. Cardiovasc Res. 2022;118(5):1289–1302. doi: 10.1093/cvr/cvab133
   PubMed Web of Science ®Google Scholar
• Tajti G, Wai DCC, Panyi G, et al. The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides. Biochem Pharmacol. 2020;181:114146. doi: 10.1016/j.bcp.2020.114146
   PubMed Web of Science ®Google Scholar
• Beeton C, Wulff H, Barbaria J, et al. Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci U S A. 2001;98(24):13942–13947. doi: 10.1073/pnas.241497298
   PubMed Web of Science ®Google Scholar
• Wulff H, Calabresi PA, Allie R, et al. The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS. J Clin Invest. 2003;111(11):1703–1713. doi: 10.1172/JCI16921
   PubMed Web of Science ®Google Scholar
• Fung-Leung WP, Edwards W, Liu Y, et al. T cell subset and stimulation strength-dependent modulation of T cell activation by Kv1.3 blockers. PLoS One. 2017;12(1):e0170102. doi: 10.1371/journal.pone.0170102
   PubMed Web of Science ®Google Scholar
• Chiang EY, Li T, Jeet S, et al. Potassium channels KV1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions. Nat Commun. 2017;8(1):14644. doi: 10.1038/ncomms14644
   PubMedGoogle Scholar
• Rus H, Pardo CA, Hu L, et al. The voltage-gated potassium channel KV1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc Natl Acad Sci U S A. 2005;102(31):11094–11099. doi: 10.1073/pnas.0501770102
   PubMed Web of Science ®Google Scholar
• Beeton C, Wulff H, Standifer NE, et al. KV1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A. 2006;103(46):17414–17419. doi: 10.1073/pnas.0605136103
   PubMed Web of Science ®Google Scholar
• Kundu-Raychaudhuri S, Chen YJ, Wulff H, et al. KV1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis–xenograft model. J Autoimmun. 2014;55:63–72. doi: 10.1016/j.jaut.2014.07.003
   PubMed Web of Science ®Google Scholar
• Tarcha EJ, Olsen CM, Probst P, et al. Safety and pharmacodynamics of dalazatide, a KV1.3 channel inhibitor, in the treatment of plaque psoriasis: a randomized phase 1b trial. PLoS One. 2017;12(7):e0180762. doi: 10.1371/journal.pone.0180762
   PubMed Web of Science ®Google Scholar
• Land J, Lintermans LL, Stegeman CA, et al. KV1.3 channel blockade modulates the effector function of B cells in Granulomatosis with polyangiitis. Front Immunol. 2017;8:1205. doi: 10.3389/fimmu.2017.01205
   PubMed Web of Science ®Google Scholar
• Lintermans LL, Stegeman CA, Munoz-Elias EJ, et al. KV1.3 blockade by ShK186 modulates CD4+ effector memory T-cell activity of patients with Granulomatosis with polyangiitis. Rheumatology (Oxford). 2023. doi:10.1093/rheumatology/kead192.
   PubMedGoogle Scholar
• Gocke AR, Lebson LA, Grishkan IV, et al. Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis. J Immunol. 2012;188(12):5877–5886. doi: 10.4049/jimmunol.1103095
   PubMed Web of Science ®Google Scholar
• Grishkan IV, Tosi DM, Bowman MD, et al. Antigenic stimulation of KV1.3-deficient Th cells gives rise to a population of Foxp3-independent T cells with suppressive properties. J Immunol. 2015;195(4):1399–1407. doi: 10.4049/jimmunol.1403024
   PubMed Web of Science ®Google Scholar
• Unterweger AL, Jensen MO, Giordanetto F, et al. Suppressing KV1.3 ion channel activity with a novel small molecule inhibitor ameliorates inflammation in a humanised mouse model of ulcerative colitis. J Crohns Colitis. 2021;15(11):1943–1958. doi: 10.1093/ecco-jcc/jjab078
   PubMed Web of Science ®Google Scholar
• Fordyce CB, Jagasia R, Zhu X, et al. Microglia KV1.3 channels contribute to their ability to kill neurons. J Neurosci. 2005;25(31):7139–7149. doi: 10.1523/JNEUROSCI.1251-05.2005
   PubMed Web of Science ®Google Scholar
• Sarkar S, Nguyen HM, Malovic E, et al. KV1.3 modulates neuroinflammation and neurodegeneration in Parkinson’s disease. J Clin Invest. 2020;130(8):4195–4212. doi: 10.1172/JCI136174
   PubMed Web of Science ®Google Scholar
• Rangaraju S, Dammer EB, Raza SA, et al. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease. Mol Neurodegener. 2018;13(1):24. doi: 10.1186/s13024-018-0254-8
   PubMedGoogle Scholar
• Maezawa I, Nguyen HM, Di Lucente J, et al. KV1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept. Brain. 2018;141(2):596–612. doi: 10.1093/brain/awx346
   PubMedGoogle Scholar
• Ramesha S, Rayaprolu S, Bowen CA, et al. Unique molecular characteristics and microglial origin of KV1.3 channel-positive brain myeloid cells in Alzheimer’s disease. Proc Natl Acad Sci U S A. 2021;118(11):e2013545118. doi: 10.1073/pnas.2013545118
   PubMed Web of Science ®Google Scholar
• Zhang X, Liang P, Zhang Y, et al. Blockade of KV1.3 potassium channel inhibits microglia-mediated neuroinflammation in epilepsy. Int J Mol Sci. 2022;23(23):14693. doi: 10.3390/ijms232314693
   PubMed Web of Science ®Google Scholar
• Nicolazzo JA, Pan Y, Di Stefano I, et al. Blockade of Microglial KV1.3 potassium channels by the peptide HsTX1[R14A] attenuates lipopolysaccharide-mediated neuroinflammation. J Pharm Sci. 2022;111(3):638–647. doi: 10.1016/j.xphs.2021.11.003
   PubMed Web of Science ®Google Scholar
• Pan Y, Kagawa Y, Sun J, et al. Peripheral administration of the KV1.3-blocking peptide HsTX1[R14A] improves cognitive performance in senescence accelerated SAMP8 mice. Neurotherapeutics. 2023;20(4):1198–1214. doi: 10.1007/s13311-023-01387-z
   PubMed Web of Science ®Google Scholar
• Chen YJ, Cui Y, Singh L, et al. The potassium channel KV1.3 as a therapeutic target for immunocytoprotection after reperfusion. Ann Clin Transl Neurol. 2021;8(10):2070–2082. doi: 10.1002/acn3.51456
   PubMed Web of Science ®Google Scholar
• Mei Y, Fang C, Ding S, et al. PAP-1 ameliorates DSS-induced colitis with involvement of NLRP3 inflammasome pathway. Int Immunopharmacol. 2019;75:105776. doi: 10.1016/j.intimp.2019.105776
   PubMed Web of Science ®Google Scholar
• Leanza L, Romio M, Becker KA, et al. Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo. Cancer Cell. 2017;31(4):516–531 e10. doi: 10.1016/j.ccell.2017.03.003
   PubMed Web of Science ®Google Scholar
• Kadow S, Schumacher F, Kramer M, et al. Mitochondrial KV1.3 channels as target for treatment of multiple Myeloma. Cancers (Basel). 2022;14(8):1955. doi: 10.3390/cancers14081955
   PubMed Web of Science ®Google Scholar
• Koni PA, Khanna R, Chang MC, et al. Compensatory anion currents in KV1.3 channel-deficient thymocytes. J Biol Chem. 2003;278(41):39443–39451. doi: 10.1074/jbc.M304879200
   PubMed Web of Science ®Google Scholar
• Fadool DA, Tucker K, Perkins R, et al. KV1.3 channel gene-targeted deletion produces “Super-Smeller mice” with altered glomeruli, interacting scaffolding proteins, and biophysics. Neuron. 2004;41(3):389–404. doi: 10.1016/S0896-6273(03)00844-4
   PubMed Web of Science ®Google Scholar
• Xu J, Wang P, Li Y, et al. The voltage-gated potassium channel KV1.3 regulates peripheral insulin sensitivity. Proc Natl Acad Sci U S A. 2004;101(9):3112–3117. doi: 10.1073/pnas.0308450100
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov. A first-in-human study to evaluate the safety, tolerability, and efficacy of Si-544 in adults with atopic dermatitis. https://classic.clinicaltrials.gov/ct2/show/NCT053833782022.
   Google Scholar
• Tyagi A, Ahmed T, Jian S, et al. Rearrangement of a unique KV1.3 selectivity filter conformation upon binding of a drug. PNAS. 2022;119(5):e2113536119. doi: 10.1073/pnas.2113536119
   PubMed Web of Science ®Google Scholar
• Panyi G, Sheng Z, Deutsch C. C-type inactivation of a voltage-gated K+ channel occurs by a cooperative mechanism. Biophys J. 1995;69(3):896–903. doi: 10.1016/S0006-3495(95)79963-5
   PubMed Web of Science ®Google Scholar
• Panyi G, Deutsch C. Cross talk between activation and slow inactivation gates of Shaker potassium channels. J Gen Physiol. 2006;128(5):547–559. doi: 10.1085/jgp.200609644
   PubMed Web of Science ®Google Scholar
• Hoshi T, Armstrong CM. C-type inactivation of voltage-gated K+ channels: pore constriction or dilation? J Gen Physiol. 2013;141(2):151–160. doi: 10.1085/jgp.201210888
   PubMed Web of Science ®Google Scholar
• Ong ST, Tyagi A, Chandy KG, et al. Mechanisms underlying C-type inactivation in KV channels: lessons from structures of human KV1.3 and fly Shaker-IR channels. Front Pharmacol. 2022;13:924289. doi: 10.3389/fphar.2022.924289
   PubMed Web of Science ®Google Scholar
• Long SB, Campbell EB, Mackinnon R. Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science. 2005;309(5736):897–903. doi: 10.1126/science.1116269
   PubMed Web of Science ®Google Scholar
• Long SB, Tao X, Campbell EB, et al. Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature. 2007;450(7168):376–382. doi: 10.1038/nature06265
   PubMed Web of Science ®Google Scholar
• Tan XF, Bae C, Stix R, et al. Structure of the Shaker KV channel and mechanism of slow C-type inactivation. Sci Adv. 2022;8(11):eabm7814. doi: 10.1126/sciadv.abm7814
   PubMed Web of Science ®Google Scholar
• Reddi R, Matulef K, Riederer EA, et al. Structural basis for C-type inactivation in a Shaker family voltage-gated K+ channel. Sci Adv. 2022;8(16):eabm8804. doi: 10.1126/sciadv.abm8804
   PubMed Web of Science ®Google Scholar
• Selvakumar P, Fernandez-Marino AI, Khanra N, et al. Structures of the T cell potassium channel KV1.3 with immunoglobulin modulators. Nat Commun. 2022;13(1):3854. doi: 10.1038/s41467-022-31285-5
   PubMed Web of Science ®Google Scholar
• Liu S, Zhao Y, Dong H, et al. Structures of wild-type and H451N mutant human lymphocyte potassium channel KV1.3. Cell Discov. 2021;7(1):39. doi: 10.1038/s41421-021-00269-y
   PubMed Web of Science ®Google Scholar
• Grissmer S, Cahalan MD. Divalent ion trapping inside potassium channels of human T lymphocytes. J Gen Physiol. 1989;93(4):609–630. doi: 10.1085/jgp.93.4.609
   PubMed Web of Science ®Google Scholar
• Levy DI, Deutsch C. Recovery from C-type inactivation is modulated by extracellular potassium. Biophys J. 1996;70(2):798–805. doi: 10.1016/S0006-3495(96)79619-4
   PubMedGoogle Scholar
• Lopez-Barneo J, Hoshi T, Heinemann SH, et al. Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels. Recept Channels. 1993;1(1):61–71.
   PubMedGoogle Scholar
• Wu X, Gupta K, Swartz KJ. Mutations within the selectivity filter reveal that KV1 channels have distinct propensities to slow inactivate. J Gen Physiol. 2022;154(11). doi: 10.1085/jgp.202213222
   PubMed Web of Science ®Google Scholar
• Busch AE, Hurst RS, North RA, et al. Current inactivation involves a histidine residue in the pore of the rat lymphocyte potassium channel RGK5. Biochem Biophys Res Commun. 1991;179(3):1384–1390. doi: 10.1016/0006-291X(91)91726-S
   PubMed Web of Science ®Google Scholar
• Nguyen A, Kath JC, Hanson DC, et al. Novel nonpeptide agents potently block the C-type inactivated conformation of KV1.3 and suppress T cell activation. Mol Pharmacol. 1996;50(6):1672–1679.
   PubMed Web of Science ®Google Scholar
• Somodi S, Varga Z, Hajdu P, et al. pH-dependent modulation of KV1.3 inactivation: role of His399. Am J Physiol Cell Physiol. 2004;287(4):C1067–76. doi: 10.1152/ajpcell.00438.2003
   PubMed Web of Science ®Google Scholar
• Pless SA, Galpin JD, Niciforovic AP, et al. Hydrogen bonds as molecular timers for slow inactivation in voltage-gated potassium channels. Elife. 2013;2:e01289. doi: 10.7554/eLife.01289
   PubMed Web of Science ®Google Scholar
• Lueck JD, Mackey AL, Infield DT, et al. Atomic mutagenesis in ion channels with engineered stoichiometry. Elife. 2016;5. doi: 10.7554/eLife.18976.
   Web of Science ®Google Scholar
• Zhang Y, Zhang X, Liu C, et al. Regulation of K+ conductance by a hydrogen bond in KV2.1, KV2.2, and KV1.2 channels. Membranes (Basel). 2021 Mar 9;11(3):190. doi: 10.3390/membranes11030190
   PubMed Web of Science ®Google Scholar
• Aiyar J, Rizzi JP, Gutman GA, et al. The signature sequence of voltage-gated potassium channels projects into the external vestibule. J Biol Chem. 1996;271(49):31013–31016. doi: 10.1074/jbc.271.49.31013
   PubMed Web of Science ®Google Scholar
• Castañeda O, Sotolongo V, Amor AM, et al. Characterization of a potassium channel toxin from the caribbean sea anemone Stichodactyla helianthus. Toxicon. 1995;33(5):603–613. doi: 10.1016/0041-0101(95)00013-C
   PubMed Web of Science ®Google Scholar
• Kalman K, Pennington MW, Lanigan MD, et al. ShK-Dap22, a potent KV1.3-specific immunosuppressive polypeptide. J Biol Chem. 1998;273(49):32697–32707. doi: 10.1074/jbc.273.49.32697
   PubMed Web of Science ®Google Scholar
• Chi V, Pennington MW, Norton RS, et al. Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases. Toxicon. 2012;59(4):529–546. doi: 10.1016/j.toxicon.2011.07.016
   PubMed Web of Science ®Google Scholar
• Tudor JE, Pallaghy PK, Pennington MW, et al. Solution structure of ShK toxin, a novel potassium channel inhibitor from a sea anemone. Nat Struct Mol Biol. 1996;3(4):317–320. doi: 10.1038/nsb0496-317
   Google Scholar
• Rashid MH, Huq R, Tanner MR, et al. A potent and KV1.3-selective analog of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases. Sci Rep. 2014;4(1):4509. doi: 10.1038/srep04509
   PubMedGoogle Scholar
• Lebrun B, Romi-Lebrun R, Martin-Eauclaire MF, et al. A four-disulphide-bridged toxin, with high affinity towards voltage-gated K+ channels, isolated from Heterometrus spinnifer (Scorpionidae) venom. Biochem J. 1997;328(Pt 1):321–327. doi: 10.1042/bj3280321
   PubMedGoogle Scholar
• Dauplais M, Lecoq A, Song J, et al. On the convergent evolution of animal toxins. Conservation of a diad of functional residues in potassium channel-blocking toxins with unrelated structures. J Biol Chem. 1997;272(7):4302–4309. doi: 10.1074/jbc.272.7.4302
   PubMed Web of Science ®Google Scholar
• Chhabra S, Chang SC, Nguyen HM, et al. KV1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases. FASEB J. 2014;28(9):3952–3964. doi: 10.1096/fj.14-251967
   PubMed Web of Science ®Google Scholar
• UniProt C, Martin M-J, Orchard S. UniProt: the universal protein knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523–D531. doi: 10.1093/nar/gkac1052
   PubMed Web of Science ®Google Scholar
• Shafee T, Mitchell ML, Norton RS. Mapping the chemical and sequence space of the ShKT superfamily. Toxicon. 2019;165:95–102. doi: 10.1016/j.toxicon.2019.04.008
   PubMed Web of Science ®Google Scholar
• Rangaraju S, Khoo KK, Feng ZP, et al. Potassium channel modulation by a toxin domain in matrix metalloprotease 23. J Biol Chem. 2010;285(12):9124–9136. doi: 10.1074/jbc.M109.071266
   PubMed Web of Science ®Google Scholar
• Galea CA, Nguyen HM, George Chandy K, et al. Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking. Cell Mol Life Sci. 2014;71(7):1191–1210. doi: 10.1007/s00018-013-1431-0
   PubMed Web of Science ®Google Scholar
• Nguyen HM, Galea CA, Schmunk G, et al. Intracellular trafficking of the KV1.3 potassium channel is regulated by the prodomain of a matrix metalloprotease. J Biol Chem. 2013;288(9):6451–6464. doi: 10.1074/jbc.M112.421495
   PubMed Web of Science ®Google Scholar
• Rauer H, Pennington M, Cahalan M, et al. Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin. J Biol Chem. 1999;274(31):21885–21892. doi: 10.1074/jbc.274.31.21885
   PubMed Web of Science ®Google Scholar
• Lanigan MD, Kalman K, Lefievre Y, et al. Mutating a critical lysine in ShK toxin alters its binding configuration in the pore-vestibule region of the voltage-gated potassium channel, KV1.3. Biochemistry. 2002;41(40):11963–11971. doi: 10.1021/bi026400b
   PubMed Web of Science ®Google Scholar
• Beeton C, Pennington MW, Wulff H, et al. Targeting effector memory T cells with a selective peptide inhibitor of KV1.3 channels for therapy of autoimmune diseases. Mol Pharmacol. 2005;67(4):1369–1381. doi: 10.1124/mol.104.008193
   PubMed Web of Science ®Google Scholar
• Pennington MW, Beeton C, Galea CA, et al. Engineering a stable and selective peptide blocker of the KV1.3 channel in T lymphocytes. Mol Pharmacol. 2009;75(4):762–773. doi: 10.1124/mol.108.052704
   PubMed Web of Science ®Google Scholar
• Chang SC, Huq R, Chhabra S, et al. N-Terminally extended analogs of the K+ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel KV1.3. FEBS J. 2015;282(12):2247–2259. doi: 10.1111/febs.13294
   PubMed Web of Science ®Google Scholar
• Zachariae U, Schneider R, Velisetty P, et al. The molecular mechanism of toxin-induced conformational changes in a potassium channel: relation to C-type inactivation. Structure. 2008;16(5):747–754. doi: 10.1016/j.str.2008.01.018
   PubMed Web of Science ®Google Scholar
• Lange A, Giller K, Hornig S, et al. Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR. Nature. 2006;440(7086):959–962. doi: 10.1038/nature04649
   PubMed Web of Science ®Google Scholar
• Sanches K, Prypoten V, Chandy KG, et al. Interaction of the inhibitory peptides ShK and HmK with the voltage-gated potassium channel KV1.3: role of conformational dynamics. J Chem Inf Model. 2023;63(10):3043–3053. doi: 10.1021/acs.jcim.2c01237
   PubMed Web of Science ®Google Scholar
• Sanches K, Wai DCC, Norton RS. Conformational dynamics in peptide toxins: implications for receptor interactions and molecular design. Toxicon. 2021;201(15):127–140. doi: 10.1016/j.toxicon.2021.08.020
   PubMedGoogle Scholar
• Sher I, Chang SC, Li Y, et al. Conformational flexibility in the binding surface of the potassium channel blocker ShK. Chembiochem. 2014;15(16):2402–2410. doi: 10.1002/cbic.201402295
   PubMed Web of Science ®Google Scholar
• Meirovitch E, Tchaicheeyan O, Sher I, et al. Structural dynamics of the potassium channel blocker ShK: SRLS analysis of 15N relaxation. J Phys Chem B. 2015;119(49):15130–15137. doi: 10.1021/acs.jpcb.5b07875
   PubMed Web of Science ®Google Scholar
• Iwakawa N, Baxter NJ, Wai DCC, et al. Conformational exchange in the potassium channel blocker ShK. Sci Rep. 2019;9(1):19307. doi: 10.1038/s41598-019-55806-3
   PubMedGoogle Scholar
• Gendeh GS, Young LC, de Medeiros CL, et al. A New potassium channel toxin from the sea anemone Heteractis magnifica: isolation, cDNA cloning, and functional expression. Biochemistry. 1997;36(38):11461–11471. doi: 10.1021/bi970253d
   PubMed Web of Science ®Google Scholar
• Pennington MW, Chang SC, Chauhan S, et al. Development of highly selective KV1.3-blocking peptides based on the sea anemone peptide ShK. Mar Drugs. 2015;13(1):529–542. doi: 10.3390/md13010529
   PubMed Web of Science ®Google Scholar
• Zhao R, Dai H, Mendelman N, et al. Tethered peptide neurotoxins display two blocking mechanisms in the K+ channel pore as do their untethered analogs. Sci Adv. 2020;6(10):eaaz3439. doi: 10.1126/sciadv.aaz3439
   PubMed Web of Science ®Google Scholar
• Ichiye T, Karplus M. Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations. Proteins. 1991;11(3):205–217. doi: 10.1002/prot.340110305
   PubMed Web of Science ®Google Scholar
• De Vries SJ, Van Dijk M, AMJJ B. The HADDOCK web server for data-driven biomolecular docking. Nat Protoc. 2010;5(5):883–897. doi: 10.1038/nprot.2010.32
   PubMed Web of Science ®Google Scholar
• Rashid MH, Kuyucak S. Affinity and selectivity of ShK toxin for the KV1 potassium channels from free energy simulations. J Phys Chem B. 2012;116(16):4812–4822. doi: 10.1021/jp300639x
   PubMed Web of Science ®Google Scholar
• Jin L, Wu Y. Molecular mechanism of the sea anemone toxin ShK recognizing the KV1.3 channel explored by docking and molecular dynamic simulations. J Chem Inf Model. 2007;47(5):1967–1972. doi: 10.1021/ci700178w
   PubMed Web of Science ®Google Scholar
• Stortelers C, Pinto-Espinoza C, Van Hoorick D, et al. Modulating ion channel function with antibodies and nanobodies. Curr Opin Immunol. 2018;52:18–26. doi: 10.1016/j.coi.2018.02.003
   PubMed Web of Science ®Google Scholar
• Doyle DA, Morais Cabral J, Pfuetzner RA, et al. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science. 1998;280(5360):69–77. doi: 10.1126/science.280.5360.69
   PubMed Web of Science ®Google Scholar
• Wang W, MacKinnon R. Cryo-EM structure of the open human ether-a-go-go-related K+ channel hERG. Cell. 2017;169(3):422–430 e10. doi: 10.1016/j.cell.2017.03.048
   PubMed Web of Science ®Google Scholar
• Zhou Y, Morais-Cabral JH, Kaufman A, et al. Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 Å resolution. Nature. 2001;414(6859):43–48. doi: 10.1038/35102009
   PubMed Web of Science ®Google Scholar
• Whicher JR, MacKinnon R. Structure of the voltage-gated K+ channel Eag1 reveals an alternative voltage sensing mechanism. Science. 2016;353(6300):664–669. doi: 10.1126/science.aaf8070
   PubMed Web of Science ®Google Scholar